UK drug price rises 'necessary', says Patrick Vallance

UK Science Minister Patrick Vallance states that price increases for medicines are necessary to prevent pharmaceutical investment from leaving the UK. Criticism points to low drug prices, lack of government investment, and pressure from the US as reasons for companies moving away. Vallance emphasizes the need for negotiations between government departments and the pharmaceutical industry to find a solution that is beneficial for the economy and patients. Major pharmaceutical companies like Moderna are investing in the UK, in contrast to others pausing or scrapping projects due to cost concerns.